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Abstract  
 
Sex differences in neurodevelopmental and common mental disorders are a ubiquitous, well-
known, though poorly understood phenomenon. This study examined the issue from three 
epidemiological perspectives: congruence in age of onset, distribution of sex-ratios with respect 
to age of onset and similarity of comorbidity and risk factor patterns. The analysis was based on 
data from the population-based PsyCoLaus study (N=4,874, age 35-82 years). Congruence in 
age of onset and distribution of sex-ratios were examined with the Mann-Whitney test and 
cluster analysis. The similarity of comorbidity and risk factor patterns, which were represented 
by 35 variables, was assessed with the Jaccard coefficient and, after factor analysis, with 
Tucker's congruence coefficient. While age of onset parameters differed little by sex, the sex 
ratio varied markedly both in early and in late onset disorders. Moreover, the Jaccard 
coefficients for most disorders indicated that the similarity of comorbidity and further 
association patterns was low. Similarly, Tucker's congruence coefficient remained below the 
range of fair similarity in all factor combinations. In sum, sex differences in common mental 
disorders were impressively reflected by diverging sex ratios and comorbidity / risk factor 
patterns. This outcome supports the notion that most mental disorders need a sex-specific 
etiopathogenetic understanding. 
 
Key words: mental disorders, neurodevelopmental disorders, sex differences, sex ratio, age of 
onset, similarity index 
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1. Introduction 
 
Sex differences in neurodevelopmental (ND) and common mental disorders (CMD) represent 
basic and relevant information for researchers and clinicians. Nevertheless, this remains one of 
the least understood topics in psychopathology. If sex differences were strong, the implications 
would be far reaching. For instance, research on etiopathogenesis that failed to differentiate 
between male and female subsamples would have produced mostly noisy results. Also, many 
findings from animal-based research, which typically relies on male animals (Beery and Zucker, 
2011), could not be generalized. 
 
It is well known that the sex ratio in common mental disorders shows a higher prevalence in 
women than in men, whereas neurodevelopmental disorders such as attention deficit 
hyperactivity disorder (ADHD), tend to be more prevalent in boys than in girls (Kessler et al., 
2005). Researchers have tackled this contrast from different perspectives. Evolutionary 
psychology / psychopathology has associated sex differences with developmental challenges 
that are different in young males and females (Del Giudice, 2016; Ellis et al., 2012). Biological 
researchers have discussed the role of adrenal hormones (Byrne et al., 2017; Del Giudice et al., 
2009) and sex hormones in the etiopathogenesis of ND/CMDs (Li and Graham, 2017; Lockshin, 
2010). One CMD supporting this notion is depression: higher prevalence rates in women do not 
appear until puberty (Angold and Costello, 2006). However, the contrast might reflect too 
strong a simplification. The susceptibility period and the onset of most neurodevelopmental 
disorders with male preponderance (autism, ADHD, stuttering) are supposed to occur before the 
onset of adrenarche. Moreover, female preponderance in anxiety disorders paradoxically also 
occurs in disorders starting before puberty, e.g. separation anxiety (Silove et al., 2015), and girls 
were found to react more strongly than boys to threats of child abuse, which is a major risk 
factor for ND/CMD (Cooke and Weathington, 2014). Conversely, there are also disorders of 
young adulthood, such as schizophrenia, with a male preponderance. In the end, each 
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susceptibility period might imply sex-specific risk factors, sex-specific comorbidities and, 
possibly, sex-specific etiopathogenetic mechanisms in ND/CMD.  
 
The aim of this study was to further scrutinize sex differences in ND/CMD using a comparative 
epidemiological approach. The study combined three basic parameters – sex-ratios, age of onset 
(AoO), and comorbidity / risk factor patterns of ND/CMD – as a novel aspect. As yet, a 
systematic comparison of sex-specific results using these different perspectives has not been 
conducted.  
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2. Methods 
 
2.1. The PsyCoLaus sample 
 
The database for this study stems from PsyCoLaus, a large population-based epidemiological 
study of mental health in the city of Lausanne (Switzerland). The survey methodology of 
PsyCoLaus has been detailed elsewhere (Preisig et al., 2009). Briefly, the cohort data were 
collected in 2003-2006 and, within a follow-up survey, in 2009-2012. The sample comprised 
4874 participants (2264 men and 2610 women) within an age range of 35 to 82 years. 
Information on ND/CMD and other comorbidities and risk factors was collected using the 
French version (Preisig et al., 1999) of the semi-structured Diagnostic Interview for Genetic 
Studies (DIGS) (Nurnberger et al., 1994) in which the anxiety sections were enriched using 
information from the Schedule for Affective Disorders and Schizophrenia - Lifetime and 
Anxiety Disorder version (SADS-LA) (Endicott and Spitzer, 1978) for the French version 
(Leboyer et al., 1991). The figures represent lifetime prevalence data. Information on age of 
onset was provided for each disorder. Ages below three years or answers such as "ever since I 
can remember" were randomly assigned a value between three and five for the age of onset and 
then rounded.  
 
The Institutional Ethics Committee of the University of Lausanne approved the 
CoLaus|PsyCoLaus study. All participants signed written informed consent forms after 
receiving a detailed description of the study’s goal and funding.  
 
The following disorders were excluded from the analysis because of their strong dependence on 
age-related environmental and cultural factors: post-traumatic stress, eating and substance use 
disorders. Moreover, few individuals had schizophrenia and other psychotic disorders, so these 
were also excluded. Specific phobias were categorized into three subtypes, namely animals, 
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other than animals and a mixed group with both an animal and another specific phobia (Ajdacic-
Gross et al., 2016)  
 
To determine sex-specific association patterns, 35 risk factors and comorbidities were included 
in the analysis. They comprised, in addition to ND/CMDs, the comorbidities stuttering, tics, 
migraine, ulcer, irritable bowel syndrome, urinary tract infections, hay fever, asthma, urticaria, 
eczema, drug allergies, fever blister (herpes simplex), acne, psoriasis, interparental violence, 
fear of punishment by parents and trauma before the age of 10.  
 
 
2.2. Statistical analysis 
 
AoO comparisons between men and women across ND/CMDs were conducted with the Mann-
Whitney U test. A k-means cluster analysis was used to split the median AoOs into clusters. 
Odds ratios were used to represent the sex ratios (women:men). To assess the similarity of 
comorbidities and association patterns across sex, the Jaccard coefficient was applied to 
significant bivariate associations between each ND/CMD and other disorders / risk factors. This 
coefficient represents the proportion of joint hits across sex related to all hits (i.e., all 
comorbidities and associations found either in males or in females). Joint absences of hits are 
excluded from the calculation. A value of 1 indicates perfect similarity, whereas 0.33 is reached 
if one half of the associations in men and one half in women are shared (on condition that the 
number of significant associations in men and women is the same). Finally, the 35 risk factors 
and mental disorders were submitted to a factor analysis in men and women and the 
corresponding factors were compared with Tucker's congruence coefficient.  
 
The analyses were conducted using SPSS (IBM, version 23). The factor analysis was carried out 
in Mplus (Version 7.4) with the EFA (exploratory factor analysis) procedure applied on 
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categorical variables. Tucker's congruence coefficient (CC) was calculated based on factor 
loadings after Promax rotation following the formula discussed in (Lorenzo-Seva and ten Berge, 
2006). 
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3. Results 
 
The distribution of the ND/CMDs across their AoO and sex ratios is shown in Table 1 and 
Figure 1. The median AoOs ranged from 5 years (y) for ADHD to 34 y for major depressive 
disorder. K-means analysis yielded a three-cluster solution for PsyCoLaus with centers at 6.7 y, 
17.2 y and 29.2 y (see vertical lines in Figure 1). The large clusters were related to childhood 
onset (n=8) and adulthood onset (n=6), respectively, whereas an intermediate cluster (n=3) was 
related to adolescence onset.  
 
The AoOs were mostly similar in men and women, although they were often slightly delayed in 
men. The Mann-Whitney U test yielded significant differences only for major depressive 
disorder (AoO 34:36 y in women:men) and mixed specific phobias (7:10 y).  
 
(Table 1 about here) 
(Figure 1 about here) 
 
The sex ratios were highest in animal phobias, mixed specific phobias and agoraphobia 
(ORs~3), and lowest in conduct and bipolar 1 disorder (ORs<0.5). The heterogeneity of sex 
ratios appeared to be greatest in the early onset cluster, followed by the adulthood onset cluster; 
it remained small in the adolescence onset cluster (ORs in the range of 1.2-1.4).  
 
In similarity analysis based on comorbidities with ND/CMD and associations with risk factors 
(see Figure 1), the Jaccard coefficients only exceptionally exceeded a high value (e.g., 
separation anxiety disorder, overanxious disorder, agoraphobia, depression). In most other 
disorders, the coefficients were around 0.33 or below, indicating more differences than 
similarities between the two sexes.  
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Finally, the ND / CMD and the risk factors were classified in factor analyses separately for men 
and women in order to calculate Tucker's CC. The factor loadings derived from the three-factor 
solution after Promax rotation are listed in Table 2. In both genders, these three factors are 
determined by the same variables: atopies, internalizing and externalizing disorders. The CC for 
the corresponding factors were 0.63 (F1(m) / F3(f)), 0.82 (F2(m) / F2(f)) and 0.76 (F3(m) / 
F1(f)), which is below the range of fair similarity (0.85-0.94) as determined by Lorenzo-Seva 
and ten Berge (2006). 
 
(Table 2 about here) 
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4. Discussion 
 
This study examined sex differences in ND/CMD from three different perspectives: the AoO, 
the sex ratio across AoO, and the congruence of comorbidities and risk factor patterns. It 
obtained three different answers, each with different implications.  
 
First, as in previous studies (Kessler et al., 2005; Lijster et al., 2017), there was a considerable 
variation in AoOs. Typically, the AoOs were slightly lower in women than in men, but these 
differences were mostly negligible. Thus, the AoO did not suggest any noteworthy sex 
differences. However, as represented by three AoO clusters in this study, the AoOs in ND/CMD 
mirror stages of sensitive developmental periods (Andersen and Teicher, 2008) and stages of 
critical brain development (Jones, 2013), i.e. in infancy and childhood as well as during and 
after puberty / adolescence.  
 
Second, the sex ratios varied considerably across the whole AoO range, thus contradicting the 
preliminary impression from the AoO comparisons. Curiously enough, the greatest spread is in 
early onset disorders (ND and early anxiety disorders), that is, before the onset of major 
hormonal changes in adrenarche and early puberty. This challenges the most common 
interpretations of the sex ratios, which refer to the impact of hormones (Byrne et al., 2017; Del 
Giudice et al., 2009; Kaestle, 2015; Li and Graham, 2017; Rubinow and Schmidt, 2019). Thus, 
the sex ratios indicate that explanatory concepts should also be considered that are not – or only 
indirectly – associated with hormonal changes.  
 
Third, the sex-specific dissimilarities were additionally accentuated when comorbidity and risk 
factor patterns were explored. The similarity indicator yielded mostly modest coefficients. 
Given that most of the ND/CMDs represent heterogeneous entities, these coefficients tend even 
to overestimate the similarity of male and female patterns. Dissimilar sex-specific comorbidity 
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and risk factor patterns suggest that the etiopathogenetic mechanisms in ND/CMDs in men and 
women are predominantly incongruent for most disorders. Up to now, this perspective has 
gained too little attention, even though sex-differences have been discussed for many disorders 
(Rutter et al., 2003).  
 
Not only the brain (Kaczkurkin et al., 2019; Nelson and Lenz, 2017; Schwarz and Bilbo, 2012) 
but also other systems relevant to ND/CMDs, such as the immune, hormonal and metabolic 
systems, develop in a sex-specific manner. Thus, sex differences in ND/CMDs cannot be 
viewed as a surprise, but they do call for appropriate responses regarding future research. 
Dissimilar sex-specific comorbidity and risk factor patterns thus suggest that the understanding 
of the pathogenesis of ND/CMDs should start with the basic assumption that most mechanisms 
are sex-specific, although some may not be (Darnall and Suarez, 2009). If the differences 
actually were small or negligible, it would be easy to unify theoretical concepts, pool research 
data, apply adjustment instead of stratification in statistical analysis. 
 
This study has several limitations. While PsyCoLaus relies on a large epidemiological sample, 
the data analyzed in this study were collected retrospectively. Thus, the study shares the 
limitations of studies based on self-reporting data, including recall-bias and telescoping effects 
(Kaestle, 2015). The concept of telescoping effects suggests that recalling tends to shift recent 
events more towards the past, whereas remote events tend to be shifted more towards the 
present time. Thus, the AoO might have been displaced by up to three years higher than the real 
age of onset (Bright and Soulakova, 2014). Furthermore, women tend to report symptoms and 
diseases more frequently than men (Ajdacic-Gross et al., 2006), so that the sex ratios with a 
female preponderance might be overrated to some extent. Due to limited recall in very early 
childhood, the lower range of the age of onset was limited to three years (Bauer, 2015). Finally, 
recall outcomes are assumed to differ according to the severity and duration of symptoms.  
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Disorders depending on environmental and cultural factors (post-traumatic stress, eating and 
substance use disorders) and disorders with small Ns (schizophrenia and other psychotic 
disorders) were excluded from the analysis. As to the comorbidities, the selection included the 
most frequent neurodevelopmental and mental disorders. As to risk factors, the selection was 
limited on the one hand by the life-time perspective on ND/CMDs and, on the other, by the 
range of self-reported information covered in the DIGS. Notably, the range of psycho-social risk 
factors was limited. Among other potential risk factors that were not considered in this analysis 
are obesity and metabolic syndrome markers, life events and social rejection, to name but a few.  
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Legends 
 
Figure 1: 
Age of onset and sex ratios of neurodevelopmental and mental disorders in PsyCoLaus (with 
frequencies and the Jaccard coefficient in brackets); vertical lines indicate the centers of the 
three age-of-onset clusters 
 
Abbreviations: 
ADHD: attention deficit hyperactivity disorder; SAD: separation anxiety disorder; OAD: 
overanxious disorder; ODD: oppositional defiant disorder; CD: conduct disorder; SOC: social 
phobia; SPPa: specific phobia / animals; SPPo: specific phobia / other than animals; SPPm: 
specific phobia / mixed animals and other subtypes; OCD: obsessive compulsive disorder; 
GAD: generalized anxiety disorder; AGO: agoraphobia; PAN: panic; DYS: dysthymia; MDD: 
major depressive disorder; BIP1: bipolar disorder type 1; BIP2: bipolar disorder type 2 
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Table 1: 
Neurodevelopmental and common mental disorders in PsyCoLaus: frequencies, sex ratios, 
median age of onset (AoO), Jaccard coefficients for similarity of comorbidity and association 
patterns; sorted by median AoO 
 
 ________________________________________________________________________________________ 
  frequencies odds ratio median AoO M-W test Jaccard 
  total men women f:m all men women p-value coefficient 
 ________________________________________________________________________________________ 
ADHD 105 62 43 0.6 5 5 5 0.88 0.21 
separation anxiety disorder 228 78 150 1.7 5 5 4 0.24 0.67 
pure animal specific phobia  164 34 130 3.4 5 6 5 0.28 0.20 
overanxious disorder 296 113 183 1.4 6 7 6 0.08 0.54 
conduct disorder 125 94 31 0.3 8 8 8 0.63 0.33 
social phobia 505 183 322 1.6 8 8 7 0.81 0.44 
mixed specific phobia 207 41 166 3.7 8 10 7 0.01 0.26 
oppositional defiant disorder 90 49 41 0.7 8 9 8 0.67 0.24 
pure other specific phobia 327 136 191 1.2 15 15 13.5 0.28 0.19 
obsessive compulsive disorder 59 23 36 1.4 16.5 19 15.5 0.51 0.37 
bipolar II 34 13 21 1.4 20 20 20 0.70 0.00 
agoraphobia 184 43 141 2.9 26 29 25 0.14 0.50 
bipolar I 45 29 16 0.5 27 26 31.5 0.41 0.33 
generalized anxiety disorder 106 37 69 1.6 28 30 28 0.77 0.37 
panic 186 51 135 2.4 30 35 30 0.07 0.30 
dysthymia 171 58 113 1.7 30 29 31 0.87 0.11 
major depression 1980 688 1292 2.2 34 36 34 0.01 0.72 
 ________________________________________________________________________________________ 
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Table 2: 
Factor analysis: loadings after Promax rotation, by sex 
 
 ________________________________________________________________________________________ 
 men women 
 factor 1 factor 2 factor 3 factor 1 factor 2 factor 3 
 ________________________________________________________________________________________ 
stuttering  0.201  0.036  0.173 0.277 -0.023  0.177 
tics 0.007  0.236  0.127 0.186  0.108  0.223 
ADHD 0.132  0.294  0.208 0.515  0.213 -0.137 
conduct disorder 0.066 -0.148  0.779 0.516 -0.023 -0.088 
oppositional defiant disorder   -0.016 -0.160  0.841 0.428  0.141 -0.065 
separation anxiety disorder   -0.128  0.413  0.194 0.113  0.437  0.042 
social phobia -0.051  0.478  0.022 0.075  0.375  0.086 
overanxious disorder 0.004  0.471  0.241 0.185  0.423  0.090 
specific phobia (only animals) -0.172  0.150 -0.097 -0.068 -0.003  0.213 
specific phobia (mixed form) -0.190  0.394  0.029 0.044  0.401  0.119 
specific phobia (no animals)   0.090  0.308 -0.141 0.083  0.233  0.030 
OCD  0.061  0.464 -0.039 0.417  0.317 -0.158 
agoraphobia   -0.073  0.703 -0.092 -0.192  0.878 -0.072 
generalized anxiety disorder -0.053  0.665 -0.130 0.214  0.376 -0.010 
panic disorder   -0.016  0.656 -0.017 -0.113  0.831 -0.086 
PTSD   -0.004  0.309  0.190 0.442  0.304  0.044 
bipolar 1 disorder -0.179  0.163  0.276 0.633 -0.369  0.177 
bipolar 2 disorder -0.287  0.092  0.057 0.578 -0.338  0.044 
major depression disorder  0.155  0.491  0.056 -0.094  0.525 -0.001 
dysthymia  0.020  0.050  0.084 0.111  0.151 -0.099 
migraine -0.061  0.216  0.036 -0.028  0.290  0.169 
interparental violence 0.028 -0.058  0.690 0.742 -0.022 -0.115 
fear of parental maltreatment 0.122  0.082  0.717 0.761  0.083 -0.051 
trauma below age of 10 -0.156  0.138  0.263 0.557  0.006  0.062 
peptic ulcer -0.215  0.208  0.088 0.254  0.052  0.145 
irritable bowel syndrome 0.160  0.365 -0.129 0.067  0.221  0.246 
urinary tract infection 0.038  0.406 -0.108 0.091  0.054  0.268 
hay fever 0.664 -0.004  0.099 -0.093 -0.167  0.667 
asthma  0.712  0.038  0.054 -0.116 -0.063  0.701 
eczema   0.238  0.179  0.072 -0.026  0.036  0.445 
urticaria 0.233  0.195 -0.078 0.001  0.012  0.645 
drug allergy 0.145  0.188  0.069 -0.005 -0.013  0.404 
fever blisters  0.021  0.231  0.028 0.008  0.126  0.161 
acne 0.073  0.303 -0.196 0.067 -0.011  0.141 
psoriasis -0.139  0.129  0.085 0.133  0.083  0.011 
 ________________________________________________________________________________________ 
 
Note: 
ADHD: attention deficit hyperactivity disorder, OCD: obsessive compulsive disorder, PTSD: post-
traumatic stress disorder 
